0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Sleep Aids in the US - Product Thumbnail Image

Sleep Aids in the US

  • Report
  • September 2024
  • 28 Pages
  • United States
From
EUR$1,190USDGBP
From
EUR$2,349USDGBP
From
EUR$2,999USDGBP
Epilepsy Therapeutics Market Report 2024-2034 - Product Thumbnail Image

Epilepsy Therapeutics Market Report 2024-2034

  • Report
  • February 2024
  • 213 Pages
  • Global
From
EUR$6,103USDGBP
Neurology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2023-2033

  • Report
  • January 2023
  • 262 Pages
  • Global
From
EUR$5,542USDGBP
Alzheimer's Therapeutics Market Report 2022-2032 - Product Thumbnail Image

Alzheimer's Therapeutics Market Report 2022-2032

  • Report
  • December 2022
  • 196 Pages
  • Global
From
EUR$5,542USDGBP
Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035 - Product Thumbnail Image

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

  • Report
  • February 2023
  • 243 Pages
  • Asia Pacific
From
EUR$5,550USDGBP
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
EUR$4,850USDGBP
Transdermal CNS Therapeutics to 2028 - Product Thumbnail Image

Transdermal CNS Therapeutics to 2028

  • Report
  • July 2023
  • 115 Pages
  • Global
From
EUR$3,850USDGBP
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
EUR$4,650USDGBP
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more